Animal models of diabetes and high fat-induced obesity commonly demonstrate pathologies leading to elevations in serum levels of cTnI and cTnT including inflammation with IL-6 and tumor necrosis factor alpha (TNF-α), and inefficient generation of ATP resulting in increased ROS production, reduced contractility, ischemia, and increased demand ischemia [21,22]. The gene discussed is TNNI3; the disease is obesity due to melanocortin 4 receptor deficiency.